Member Info for Guly

Wow huge news. Should see 50% when the market catches on.

Doesn't appear to be much stock available - could get really interesting.

Market slowly catching on looking very strong.

Sales are growing in line with expectations and a very supportive new investor. In 2 years time you could be looking at huge free cash flow.

Product is in demand and growth will accelerate. Massively derisked now.

Can see this one doing incredibly well. Now fully cashed up to meet the demand for its product.

Crazy undervalution here particularly with Dennis Purcell pulling the strings as Chairman

Could go crazy from here. Not much stock available.

Amazing interview from Dennis Purcell. We're really going places with him as Chairman. Medium to long term 5p isn't out of the question if it all goes to plan. His reputation speaks for itself.

Amazing interview

Agree tricky - holding RNS soon.

1p is just a drop in the ocean with Dennis P on board

The pharma industry is all about who can open doors - Dennis P that man.

Only 1 drug in phase 3, another in phase 2 plus IP and patents. huge connections in Dennis P. All for just £9m mcap or so, should be atleast 3 times as much.

Now

Market oblivious to the opportunity here - one of my easiest holds. So much going on - all we know need is milestone deals and the sky is the limit.

Rainbow chasers will regret selling - potential monster in the making with Dennis Purcell pulling the strings. Milestone deals with big pharma next IMO.

I don't look at number of shares in issue. All that matters is the intellectual property and prospects relative to the current valuation. You won't find many clinical pharmas at the new valuation. We are easily worth £30-40m merged.

Dennis building a company with sufficient scale to land deals with big pharma. Progressing much quicker than I initially anticipated - medium to long term we could be looking at 5p+.

Market so short sighted its unbelievable. When the true investors arrive we will see 0.50+

Correction value accretive